Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06839313

Effect of St. John's Wort in the Treatment of Recurrent Aphthous Stomatitis

Comparative Evaluation of the Effect of Hypericum Perforatum on Pain Level in the Treatment of Recurrent Aphthous Stomatitis:A Randomized Clinical Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
75 (estimated)
Sponsor
Batman University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The aim of the treatment of Recurrent Aphthous Stomatitis (RAS) is to accelerate the healing of ulcers by reducing pain and inflammation, thus enabling patients to perform their oral functions comfortably. It has been said many times in the literature that St. John's wort is very effective in wound healing.In this study, the evaluation of the therapeutic effects of St. John's wort extract on the clinical symptoms and ulcer healing rate in patients with Recurrent Aphthous Stomatitis (RAS), a condition with no definitive treatment, was aimed.

Detailed description

he etiology of Recurrent Aphthous Stomatitis (RAS) remains incompletely understood. Various therapeutic approaches, including topical and systemic agents, have been employed to alleviate pain, reduce ulcer dimensions, and prolong disease-free intervals. First-line management of RAS typically involves topical pharmacological agents. Among these, triamcinolone acetonide (TA), a corticosteroid derivative, is extensively utilized in the treatment of moderate-to-severe RAS due to its anti-inflammatory properties. Hyaluronic acid (HA) gel, a more recent therapeutic option, has been demonstrated to effectively mitigate pain associated with RAS without inducing systemic or local adverse effects. Furthermore, Hypericum perforatum (St. John's Wort) has gained significant attention in the scientific community owing to its pharmacological properties, including antiviral, antibacterial, antioxidant, and anti-inflammatory effects. Studies evaluating the topical application of Hypericum perforatum extract in wound healing have indicated that it significantly enhances tissue repair and regeneration. This study aims to compare the efficacy of triamcinolone acetonide, hyaluronic acid gel, and Hypericum perforatum extract in pain management and ulcer size reduction in patients with RAS.

Conditions

Interventions

TypeNameDescription
DRUGKenacort A Orabase® pomad , Bristol-Myers Squibb İlaçları Inc. İstanbul , TürkiyeApply to the injured area 4 times a day
COMBINATION_PRODUCTHyaluronic acid, Aftamed ® Oral jel , AktiFarma . İstanbul, TürkiyeApply to the injured area 4 times a day
COMBINATION_PRODUCTSt. John's wort oil, Zade Vital; Health&Fitness, Developed With Ege Üniversiesi ArgefarApply to the injured area 4 times a day

Timeline

Start date
2025-02-01
Primary completion
2025-03-31
Completion
2025-04-15
First posted
2025-02-21
Last updated
2025-02-25

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06839313. Inclusion in this directory is not an endorsement.